Drug-induced lupus is more common in men because they are given these drugs more often; however, not everyone who takes these drugs will develop the disease. Specific criteria for diagnosing ...

“The European approval of Benlysta represents a significant milestone, and we are very pleased to be able to provide physicians an additional therapeutic option for treating appropriate patients with ...

New York, NY - While there have certainly been some bumps in the road during recent weeks, some targeted SLE therapies in the pipeline still show tremendous promise, according to Dr Joan T Merrill ...

BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory systemic lupus erythematosus (SLE) get symptoms under control, according ...

Symptom control Use of rapidly acting agents tailored to the nature and severity of the manifestation Glucocorticoids: topical for mild cutaneous lupus; low-dose oral for mild disease; moderate to ...

The total market size of systemic lupus erythematosus is expected to increase in the 7MM during the forecast period, driven by ongoing clinical research of therapies such as nipocalimab (Johnson & ...

BARCELONA -- A small-molecule oral drug shaping up as a first-in-class to treat various forms of lupus performed well in a phase II trial, despite -- or perhaps even because of -- missing its primary ...

This guideline from the American College of Rheumatology reinforces the prevailing belief that hydroxychloroquine (HCQ) should be the backbone of lupus treatment for most patients. Corticosteroids may ...

A University of Houston researcher has found a plant-derived compound that shows some promise in combatting the autoimmune disease lupus. Lupus is a progressive, incurable disease that attacks the DNA ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Lupus affects women at disproportionately high rates— roughly 9 out of 10 patients are female —and research consistently ...